Maximilian Winter is a fourth-generation entrepreneur from a top-500 German family business with a rich history spanning over 70 years. His expertise encompasses managing a large-scale family enterprise, family office, and philanthropic foundation devoted to improving society. Maximilian is particularly excited about the unique opportunity to transform the healthcare sector.
Maximilian’s primary focus is on fostering the growth and evolution of his family office, family business, foundation, and venture capital firm – all united in their mission to make meaningful contributions to humankind. His experience has driven success and innovation across multiple domains.
Maximilian dedicates himself to advancing human health and infrastructure through technology and leadership. He does this by investing in scalable scientific breakthroughs alongside his team at Harmonix and collaborating with a community of kindred spirits embodying his aspirations and principles.
Krish Ramadurai is a Partner at Harmonix Fund, leading the firm’s technical due diligence, investment sourcing, and portfolio operational support across their healthcare, life sciences, and deep technology practices. He is a multi-published author, advisor, lecturer, and former researcher at Harvard & MIT. While at Harvard, he worked with Nobel Laureate Economist Michael Kremer on the United States Agency for International Development’s Innovation Ventures Fund and authored three books on medicine and applied engineering. He serves as a venture advisor for Nucleate and is a board observer for Sorcero and xCures. He has been nominated for multiple industry awards including Forbes 30 Under 30 in venture capital and the NVCA Rising Star Award. He has advanced degrees in Biology, Nanotechnology & Nanomedicine, and Business Administration from Harvard University, Oxford University, and Washington University in St. Louis, respectively, and a bachelor’s degree in Integrative Biology and Economics with a Chemistry minor from the University of Illinois at Urbana-Champaign. In his spare time, he enjoys traveling and is an avid classic car enthusiast.
Cofield is Chief Operating Officer and partner at Harmonix, where she provides strategic support for the fund and its 40+ companies.. She is a founder and business leader with 30+ years of experience in operational roles.
Cofield grew up in South Africa, and has lived in Botswana, Kenya, London and the United States. She managed and led teams of up to 45+ in various verticals, including interior lifestyle brands, import and export and the entertainment industry.
Cofield is also an accomplished recording artist who was signed to Sony and Universal Music and is an Ambassador for the 46664 Nelson Mandela Foundation.
During her career in the entertainment industry, Cofield nurtured, managed and developed talent for the global stage.
Her unique specialty is coaching, negotiating and evaluating character for assembling successful teams, which she artfully brings to her role in Venture Capital.
Managing Director of Marketing and Investor Relations
Anthony DeFeo serves as the Managing Director of Marketing and Investor Relations at Harmonix, where he spearheads strategic initiatives to drive brand awareness, investor engagement, and market growth.
DeFeo is a seasoned professional with a wealth of experience in the financial industry. With over 15 years of experience, he has successfully raised over $1 billion in capital throughout his career.
Before joining Harmonix, Anthony held a similar role at CKC Capital, a corporate credit-focused hedge fund. Demonstrating his versatility, Anthony also acquired valuable expertise in the healthcare sector, serving as a marketer for Orchard View Capital and Sio Capital, two prominent hedge funds renowned for their specialization in healthcare investments.
Early in his career, Anthony served as a Marketing Associate at Exis Capital. Notably, Anthony’s professional journey began at JPMorgan Chase & Co., where he excelled as an Assistant Vice President Relationship Manager.
Anthony obtained his Master of Business Administration (MBA) from Fordham University, where he was the President of his graduating class. Prior to his MBA, he earned a Bachelor of Arts in Italian language from New York University. In his free time, Anthony enjoys golf, running, baseball, and spending time with his family.
Paul has over 20 years of experience as a scientist and entrepreneur developing and commercializing tools in genomics and DNA sequencing.
Anna has 20+ years of senior global leadership roles at Roche and Illumina.
Dr. David Messina is the COO of Cofactor Genomics and has spent the last 20+ years in computational biology and genetics.
Founder and CEO of 3 diagnostic companies
PhD in Neurobiology (Alzheimer’s research), MS in Biochemistry( Cancer research)
Research with Nobel Laureate Roger Kornberg at Stanford University
VC experience in Health Tech and Biotech
Director of External Innovation at Dewpoint Therapeutics.
Previous Director of Healthcare & Life Sciences at Harvard Innovation Labs.
Co-led planning of Life Lab Longwood at Harvard Medical School.
Former Assistant Professor of Biomedical Engineering and Director of the Center for Medical Materials & Biophotonics at Florida Institute of Technology.
Ph.D. in Biomedical Engineering, M.S. in Materials Science and Engineering, and B.S. in Chemistry/Biochemistry, all from the University of Florida.
Served as cofounder & advisor for multiple startups.